EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 117 filers reported holding EDITAS MEDICINE INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $348 | +63.4% | 44,675 | +51.9% | 0.04% | +75.0% |
Q1 2023 | $213 | -100.0% | 29,414 | -42.8% | 0.02% | -67.7% |
Q3 2022 | $630,000 | +126.6% | 51,435 | +118.9% | 0.06% | +100.0% |
Q2 2022 | $278,000 | +20.3% | 23,502 | +102.1% | 0.03% | -31.1% |
Q1 2020 | $231,000 | -44.1% | 11,628 | -52.7% | 0.04% | -42.3% |
Q2 2017 | $413,000 | +53.5% | 24,593 | +103.9% | 0.08% | +23.8% |
Q1 2017 | $269,000 | – | 12,059 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |